An enzyme that extends telomeres by adding repetitive DNA sequences.Telomerase is an enzyme that rebuilds the protective caps at the ends of chromosomes, called telomeres. Chromosomes are the long threads of DNA that carry our genes, and their tips fray a little each time a cell divides. Telomeres act like the plastic tips on shoelaces, keeping the DNA from unraveling or being mistaken for damage. In most cells, telomeres shorten with every division, and when they become too short, the cell stops dividing and may die. Telomerase counteracts this by adding fresh repeats of a short DNA sequence onto the chromosome ends, effectively resetting the clock. It is active in cells that need to divide many times, such as stem cells and immune cells, but is largely switched off in most adult tissues. In cancer cells, telomerase is often reactivated, allowing them to divide indefinitely.
Telomerase was discovered in 1984 by Elizabeth Blackburn and Carol Greider while working with the pond organism Tetrahymena. They found that extracts from this organism could add telomeric repeats to DNA ends. Blackburn, Greider, and Jack Szostak received the 2009 Nobel Prize in Physiology or Medicine for this work and for showing how telomeres and telomerase protect chromosomes.
Telomerase is a ribonucleoprotein: it contains both a protein component (the reverse transcriptase TERT) and an RNA molecule (TERC). The RNA part serves as a template, and the protein part uses that template to synthesize new DNA repeats onto the end of the chromosome. Essentially, it is a specialized reverse transcriptase that carries its own built-in template. By repeatedly copying a short sequence from its RNA onto the DNA end, telomerase can extend the telomere by many repeats. This extension allows the normal DNA replication machinery to finish copying the chromosome without losing vital genetic information.
Telomerase is a major target in cancer research, with drugs designed to inhibit it in tumors, and it is also studied for its potential to treat age-related diseases and to extend the lifespan of cells in regenerative medicine.
Some single-celled organisms, like Tetrahymena, have telomerase active all the time and maintain telomeres of constant length, effectively making them biologically immortal under the right conditions.